Audio recording of September 2026 results call posted

Investor Communications View source PDF Explain this filing

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹454.50

prior close

₹460.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-3.4% vs market

Pharmaceuticals peers, median of 171sector+0.5%-2.8% vs sector

On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 2.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.7

10m

-1.2

15m

-1.2

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3+1.1-3.4+0.5-2.8

Next day

-1.9pendingpending+0.4-2.3

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 171Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aarti Drugs has uploaded the audio recording of its investor and analyst conference call on the financial results for the quarter and half year ended September 30, 2026. The transcript will be shared with the exchanges and uploaded on the company website later.

Likely market impact

The filing contains no new financial targets or guidance. Investors should review the recording and transcript for operational and outlook details.